Teva-Losartan (2021-08-26)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Teva-Losartan
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 1070917, 1020419, 1030419 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Teva-Losartan | DIN 02357968 | Tablet | Losartan Potassium 50 Mg |
| 2050419 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Teva-Losartan | DIN 02357976 | Tablet | Losartan Potassium 100 Mg |
| 0040917 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Teva-Losartan | DIN 02380838 | Tablet | Losartan Potassium 25 Mg |
Presence of Losartan Azide impurity above the acceptable limit.